Sweden's Medicover Q3 profit rises 29% on price adjustments and wider network; to focus on Europe

Medicover AB

04/11/2026 06:54

Overview
Sweden healthcare and diagnostics firm's Q3 revenue grew 6% yr/yr, with organic growth of 8%
Q3 net profit rose 29% and EPS increased 28% from prior year
Company announced divestment of Indian hospital business, expected to close in Q4

Outlook
Medicover expects continued softness in public reimbursement and tariff mix in key markets
Company sees constrained public care access supporting demand for private-pay channels
Medicover to focus on European markets and adapt offerings to demand and market conditions

Result Drivers
ORGANIC GROWTH - Co said organic growth of 8% in Q3 was driven by price adjustments and network expansion
PORTFOLIO OPTIMISATION - Co said closing less profitable units and opening new facilities improved efficiency and supported profitable growth
DIVESTMENT - Co said divestment of Indian hospital business will create a more focused provider across European markets and strengthen financial position

Company press release: ID:nMFN28PfbT

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
 
EUR 570.80 mln
 
Q3 EPS
 
EUR 0.162
 
Q3 EBIT
 
EUR 49.30 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Medicover AB is SEK300.00, about 8.7% above its November 3 closing price of SEK276.00
The stock recently traded at 31 times the next 12-month earnings vs. a P/E of 27 three months ago

Reuters Recommended Reads
Nov 4 - Sweden's Ambea Q3 sales rise on higher occupancy, operational improvements
Nov 3 - PACS Group Q3 revenue beats on higher occupancy rates
Nov 3 - Senior care provider InnovAge's Q1 revenue beats as participants increase

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)